国家能力对COVID-19疫苗接种率跨国差异的影响
The impact of state capacity on the cross-country variations in COVID-19 vaccination rates
摘要:
在疫苗接种的初期,各国的疫苗接种工作在疫苗接种进程的开始和接种人数的动态方面都存在很大的差异。关于这种观察到的异质性的驱动因素的持续辩论中的一个主要论点是,迅速和广泛推出疫苗的一个关键决定因素是国家能力。在这里,我们使用两个量化国家能力不同方面的指标:i)外部能力(通过国家的软实力和经济实力衡量)和ii)内部能力(通过国家的政府效率衡量),并调查它们与初始阶段(截至2021年1月30日)冠状病毒疫苗接种结果的关系。通过使用189个国家的数据和两步Heckman方法,我们发现,国家的经济实力和软实力是一个国家是否开始接种疫苗的决定因素。此外,政府的有效性是决定疫苗推广的关键因素。总而言之,我们的研究结果符合国家能力决定COVID-19疫苗推广初期国家间观察到的异质性的假设。
英文摘要:
The initial period of vaccination shows strong heterogeneity between countries' vaccinations rollout, both in the terms of the start of the vaccination process and in the dynamics of the number of people that are vaccinated. A predominant thesis in the ongoing debate on the drivers of this observed heterogeneity is that a key determinant of the swift and extensive vaccine rollout is state capacity. Here, we utilize two measures that quantify different aspects of the state capacity: i) the external capacity (measured through the soft power and the economic power of the country) and ii) the internal capacity (measured via the country's government effectiveness) and investigate their relationship with the coronavirus vaccination outcome in the initial period (up to 30th January 2021). By using data on 189 countries and a two-step Heckman approach, we find that the economic power of the country and its soft power are robust determinants of whether a country has started with the vaccination process. In addition, the government effectiveness is a key factor that determines vaccine roll-out. Altogether, our findings are in line with the hypothesis that state capacity determines the observed heterogeneity between countries in the initial period of COVID-19 vaccines rollout.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。